[HTML][HTML] Cystic fibrosis gene therapy: looking back, looking forward

AL Cooney, PB McCray Jr, PL Sinn - Genes, 2018 - mdpi.com
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR) gene that encodes a cAMP …

[HTML][HTML] Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide

F Kreppel, S Kochanek - Molecular Therapy, 2008 - cell.com
The chemical modification of adenovirus (Ad) gene transfer vectors with synthetic polymers
is a promising strategy for overcoming typical in vivo hurdles associated with Ad-mediated …

An in vitro model of differentiated human airway epithelia: methods for establishing primary cultures

PH Karp, TO Moninger, S Pary Weber… - Epithelial cell culture …, 2002 - Springer
The human airway epithelium forms a barrier between the external and internal
environments, separating air from the interstitial space. However, it also serves many other …

[HTML][HTML] Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an …

L Guillot, S Medjane, K Le-Barillec, V Balloy… - Journal of Biological …, 2004 - ASBMB
Pulmonary epithelial cells are continuously exposed to microbial challenges as a result of
breathing. It is recognized that immune myeloid cells express Toll-like receptors (TLRs) …

[HTML][HTML] CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium

L Zhang, B Button, SE Gabriel, S Burkett, Y Yan… - PLoS …, 2009 - journals.plos.org
Dysfunction of CFTR in cystic fibrosis (CF) airway epithelium perturbs the normal regulation
of ion transport, leading to a reduced volume of airway surface liquid (ASL), mucus …

Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus

NK Green, CW Herbert, SJ Hale, AB Hale, V Mautner… - Gene therapy, 2004 - nature.com
Systemic delivery of adenoviral vectors is a major goal in cancer gene therapy, but is
currently prohibited by rapid hepatic uptake of virus following intravenous injection with …

Barriers to inhaled gene therapy of obstructive lung diseases: A review

N Kim, GA Duncan, J Hanes, JS Suk - Journal of Controlled Release, 2016 - Elsevier
Abstract Knowledge of genetic origins of obstructive lung diseases has made inhaled gene
therapy an attractive alternative to the current standards of care that are limited to managing …

Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis

S Ferrari, DM Geddes, EWFW Alton - Advanced drug delivery reviews, 2002 - Elsevier
Clinical trials of gene therapy for cystic fibrosis suggest that current levels of gene transfer
efficiency are probably too low to result in clinical benefit, largely as a result of the barriers …

Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation

W Xiao, YP Hsu, A Ishizaka, T Kirikae, RB Moss - Chest, 2005 - Elsevier
Background Interest in airways inflammatory disease has increasingly focused on innate
immunity. We investigated several components of innate immunity in induced sputum of …

Targeted adenoviral vectors

BG Barnett, CJ Crews, JT Douglas - Biochimica et Biophysica Acta (BBA) …, 2002 - Elsevier
Replication-defective vectors based on human adenovirus serotypes 2 and 5 (Ad2 and Ad5)
possess a number of attributes which favor their use as gene delivery vehicles in gene …